Does SODIUM, MONOBASIC Cause Hyperphosphataemia? 86 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 86 reports of Hyperphosphataemia have been filed in association with SODIUM, MONOBASIC. This represents 38.1% of all adverse event reports for SODIUM, MONOBASIC.
86
Reports of Hyperphosphataemia with SODIUM, MONOBASIC
38.1%
of all SODIUM, MONOBASIC reports
86
Deaths
80
Hospitalizations
How Dangerous Is Hyperphosphataemia From SODIUM, MONOBASIC?
Of the 86 reports, 86 (100.0%) resulted in death, 80 (93.0%) required hospitalization, and 75 (87.2%) were considered life-threatening.
Is Hyperphosphataemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SODIUM, MONOBASIC. However, 86 reports have been filed with the FAERS database.
What Other Side Effects Does SODIUM, MONOBASIC Cause?
Hyponatraemia (185)
Stress (183)
General physical health deterioration (182)
Multiple organ dysfunction syndrome (182)
Sepsis (180)
Vomiting (178)
Appendicitis (177)
Ascites (177)
Appendicolith (176)
Abdominal distension (174)
What Other Drugs Cause Hyperphosphataemia?
ALLOPURINOL (139)
LANSOPRAZOLE (138)
ACETAMINOPHEN (132)
SEVELAMER (129)
ONDANSETRON (127)
CALCITRIOL (125)
IPRATROPIUM (123)
ALBUTEROL (122)
METRONIDAZOLE (120)
HYDROMORPHONE (118)
Which SODIUM, MONOBASIC Alternatives Have Lower Hyperphosphataemia Risk?
SODIUM, MONOBASIC vs SODIUM MONOFLUOROPHOSPHATE
SODIUM, MONOBASIC vs SODIUM NITROPRUSSIDE
SODIUM, MONOBASIC vs SODIUM OXYBATE
SODIUM, MONOBASIC vs SODIUM PHENYLBUTYRATE
SODIUM, MONOBASIC vs SODIUM PHENYLBUTYRATE\TAURURSODIOL